Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2015

Conditions
Cystic Fibrosis
Interventions
DIETARY_SUPPLEMENT

Docosahexanoic Acid Supplement

"The active treatment will consist of Martek's chewable DHA capsules containing 200mg in each capsule. The treatment will be provided as approximately 25mg/kg/day and 35mg/kg/day.~These dosages will be divided BID-TID and will be given for 4 weeks."

DIETARY_SUPPLEMENT

Placebo

Placebo identical to active treatment.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00924547 - Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis | Biotech Hunter | Biotech Hunter